Porous microparticles as a tool for minimizing 5-Fluorouracil induced intestinal mucositis.
Authors:
Open Access
- 1 January 2024
- journal article
- Published by Egyptian Knowledge Bank in Merit Medical Journal
- Vol. 1 (1) , 21-27
Abstract
5 Fluorouracil (5-FU) is used primarily to treat solid malignant tumors and is administered via the intravenous route; however, this administration is accompanied by intestinal mucositis, represented by diarrhea. In this work, 5-FU microsponges (porous microparticles) were prepared to be taken orally to minimize the intestinal mucositis associated with the intravenous IV administration of 5-FU. 15 male albino rabbits were utilized to compare the degree of intestinal mucositis related to the intravenous administration to that of 5-FU microsponges capsule oral administration (at the same dose). The experiment was conducted for five consecutive days. Results showed that the mean villus height of the IV group measured about 260.0± 6.9 µm, which was considerably lower (p<0.05) than that of the Capsule group, which measured about 285.0± 9.3 µm; in addition, the mean depth of crypts of IV group measured about 110.0± 6.8 µm which is significant (p<0.05) lower than that of Capsule group which measured about 141.0± 7.8 µm which means that the degree of intestinal mucositis induced by the intravenous injection of 5-FU was significantly higher than that caused by that of oral administration of 5- FU microsponges formulation. By the way, on the fourth day, one rabbit of the IV group died, indicating the severity of the intestinal mucositis after the IV administration of 5-FU. The results showed that the oral administration of 5-FU microsponges is more safe than IV drug administration at the same dose.Keywords
This publication has 18 references indexed in Scilit:
- Ascorbic acid attenuates antineoplastic drug 5-fluorouracil induced gastrointestinal toxicity in rats by modulating the expression of inflammatory mediatorsToxicology Reports, 2015
- Combinatorial anticancer effects of curcumin and 5-fluorouracil loaded thiolated chitosan nanoparticles towards colon cancer treatmentBiochimica et Biophysica Acta (BBA) - General Subjects, 2014
- Oral 5-fluorouracil colon-specific delivery through in vivo pellet coating for colon cancer and aberrant crypt foci treatmentInternational Journal of Pharmaceutics, 2014
- Inflammatory intestinal damage induced by 5-fluorouracil requires IL-4Cytokine, 2013
- Design and characterization of colon-specific drug delivery system containing paracetamol microspongesArchives of Pharmacal Research, 2011
- In Vivo Evaluation of 5-Fluorouracil-Containing Self-Expandable Nitinol Stent in Rabbits: Efficiency in Long-Term Local Drug DeliveryJournal of Pharmaceutical Sciences, 2010
- Determination of S-1 (combined drug of tegafur, 5-chloro-2,4- dihydroxypyridine and potassium oxonate and 5-fluorouracil in human plasma and urine using high-performance liquid chromatography and gas chromatography-negative ion chemical ionization mass spectrometryJournal of Chromatography B: Biomedical Sciences and Applications, 1997
- Determination of the concentrations of 5-fluorouracil and its metabolites in rabbit plasma and tissues by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1994
- Flow characteristics of loosely compacted macroporous microsponge® polymeric systemsPowder Technology, 1994
- Determination of 5-fluorouracil in plasma and whole blood by ion-pair high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1988